HANCOCK WHITNEY CORP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$124,000
-67.9%
12,444
-59.6%
0.01%
-61.5%
Q4 2018$386,000
-32.3%
30,771
-20.0%
0.01%
-18.8%
Q3 2018$570,000
-20.2%
38,440
-9.4%
0.02%
-51.5%
Q2 2018$714,00042,4100.03%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 1,932,123$44,246,0004.48%
Ghost Tree Capital, LLC 350,000$8,015,0001.62%
INGALLS & SNYDER LLC 1,322,062$30,275,0001.48%
SENZAR ASSET MANAGEMENT, LLC 199,139$4,561,0001.44%
Matarin Capital Management, LLC 285,450$6,536,805,0000.49%
KNOTT DAVID M 49,557$1,135,0000.47%
Spark Investment Management LLC 144,600$3,311,0000.21%
PRINCETON CAPITAL MANAGEMENT LLC 16,582$380,0000.17%
TIVERTON ASSET MANAGEMENT LLC 77,782$1,781,0000.12%
CADENCE CAPITAL MANAGEMENT LLC 82,240$1,883,0000.12%
View complete list of CONCERT PHARMACEUTICALS INC shareholders